CAPILLARY ELECTROPHORESIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global Capillary Electrophoresis Market Size and Forecast – 2025 to 2032

The global capillary electrophoresis market is estimated to be valued at USD 391.5 Mn in 2025 and is expected to reach USD 569.5 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. This steady growth is driven by increasing applications in pharmaceutical analysis, biotechnology, and clinical diagnostics, highlighting the market's robust expansion potential over the forecast period.

Key Takeaways of the Global Capillary Electrophoresis Market

• In 2025, instruments (automatic systems, semi‑automatic systems) segment is expected to lead the global capillary electrophoresis market with 55.2% share.
• The Capillary Zone Electrophoresis (CZE) segment is projected to hold the largest share at 24.5% share in 2025.
• Nucleic acid analysis (DNA/RNA sequencing, fragment analysis) segment is projected to account for 23.5% of the market share in 2025.
• North America is expected to lead the market, holding a share of 40.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with an estimated market share of 23.5% in 2025.

Market Overview

Market trends indicate a rising demand for high-resolution analytical techniques, with capillary electrophoresis gaining prominence due to its efficiency, accuracy, and low sample requirements. Technological advancements, including integration with mass spectrometry and automation, are further propelling the market adoption. Additionally, growing emphasis on personalized medicine and regulatory compliance is driving the need for precise biomolecular analysis, positioning capillary electrophoresis as a critical tool in modern laboratories worldwide.

Currents Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights 

To learn more about this report, Download Free Sample

Capillary Electrophoresis Market Insights, By Product – Instruments (automatic systems, semi‑automatic systems) Segment Dominates Due to their Widespread Adoption and Enhanced Operational Efficiency in Laboratories

By 2025, the global capillary electrophoresis market will be dominated by instruments (automatic systems, semi‑automatic systems) with a share of 55.2%. High efficiency, ease of use, and the growing need to automate clinical, research, and biopharmaceutical procedures result in this growth. Complex electrophoretic processes are made simpler, more precise and reproducible using automated systems, which is highly essential in high-throughput settings like pharmaceutical research and clinical diagnostics.

In September 2020, Promega, a leading manufacturer of reagents and STR kits, launched the Spectrum Compact CE System. Developed in collaboration with Hitachi High-Tech, a top capillary electrophoresis developer, the personal capillary electrophoresis system enables scientists to perform Sanger sequencing and fragment analysis.

Capillary Electrophoresis Market Insights, By Mode - Capillary Zone Electrophoresis (CZE) Maintains Market Leadership due to its Versatility, Robustness, and Reliable Analytical Capabilities

The Capillary Zone Electrophoresis (CZE) segment captures the greatest share considering its flexibility and strength as an analytical method with a market share of 24.5% in 2025. The inherent strengths of CZE, namely, a high resolution, a quick analysis, and a low sample preparation, are required to consider it as an essential instrument of separating ionic species on the basis of the charge-to-size ratio.

This primary property makes CZE applicable to a great number of applications, including nucleic acid analysis, protein characterization and pharmaceutical impurity profiling, without requiring significant method redevelopment.

Capillary Electrophoresis Market Insights, By Application – Nucleic Acid Analysis (DNA/RNA sequencing, fragment analysis) Remains Key Application Area with High Demand from Diagnostics Fields

Nucleic acid analysis (DNA/RNA sequencing, fragment analysis), is the largest segment in the global capillary electrophoresis market with 23.5% share in 2025, due to its high demand in the genomics, medical research, and diagnostics field.

The accuracy and sensitivity of the capillary electrophoresis technique in the separation of nucleic acid fragments form the basis of its popularity in genetic testing workflows, where precise sizing and quantification of DNA and RNA is important. The recent emergence of personalized medicine and subsequent requirement of further genetic profiling has brought nucleic acid analysis into the limelight.

Regional Insights 

To learn more about this report, Download Free Sample

North America Capillary Electrophoresis Market Analysis and Trends

North America capillary electrophoresis market is set to maintain dominance with a 40.3% share of the global market in 2025. This is attributed to superior healthcare infrastructure, significant research and development (R&D), and the presence of leading biotechnology and pharmaceutical firms. The region also boasts a strong ecosystem of top research institutions and universities actively engaged in technological innovations for analysis.

The government policies in the U.S. and Canada are in favor of life sciences developments and it funds and controls high-precision devices such as capillary electrophoresis systems. SCIEX, Agilent Technologies and Bio-Rad Laboratories are some of the key players dominating the market as they offer CE solutions to clinical diagnostics and pharmaceutical quality control.

Asia Pacific Capillary Electrophoresis Market Analysis and Trends

Asia Pacific capillary electrophoresis market is expected to witness the fastest growth with a share of 23.5% in 2025. Rising health care infrastructure, the growing knowledge of high-tech diagnostic methodologies, and rising pharmaceutical production are contributing to the regional market growth.

Biotech industries in China, Japan, South Korea and India are experiencing an increasing demand for analytical instruments as the governments are striving to strengthen their healthcare and R&D. Other corporations like Shimadzu Corporation, Hitachi High-Technologies, and Tosoh Corporation are also contributing significantly. They usually partner with the local companies to customize their products to suit the needs of the region.

Adoption of Capillary Electrophoresis (CE) Across Key Applications

Genomics

• Capillary Electrophoresis (CE) is widely used for Deoxyribonucleic Acid (DNA)/Ribonucleic Acid (RNA) sequencing, genotyping, and fragment analysis in genomic research.
• It’s valued for high resolution and low sample consumption, especially for nucleic acid separations.
• Adoption is driven by increased DNA sequencing demand and the need for automated workflows.

Proteomics

• CE, including Capillary Electrophoresis-Mass Spectrometry (CE-MS), is increasingly used for protein/peptide separation, glycan profiling, and biomarker discovery.
• Its high sensitivity and low sample volume make it suitable for proteomic applications.
• Growth is driven by the rise of biopharmaceuticals and the need for advanced analysis in biologics quality control (QC).

Pharmaceutical Quality Control (QC)

• CE is used for impurity profiling, charge variant analysis, and stability testing in pharmaceutical formulations.
• Adoption is supported by regulatory drivers and the pharmaceutical industry's need for high-resolution quality control (QC).
• However, cost and throughput limitations compared to alternatives like High-Performance Liquid Chromatography (HPLC)/Liquid Chromatography-Mass Spectrometry (LC-MS) slow broader uptake.

Clinical Diagnostics

• CE is applied in clinical labs for genetic disorder diagnostics, protein/peptide profiling, and hemoglobin variant separation.
• Its adoption is increasing in diagnostics due to the demand for precision medicine and automated systems.
• However, many clinical labs still prefer established platforms, so CE adoption remains incremental.

Global Capillary Electrophoresis Market Outlook for Key Countries

U.S. Capillary Electrophoresis Market Trends

The capillary electrophoresis market in the U.S. boasts of the advanced research centers as well as the high density of the pharmaceutical and biotechnology industries. The strict quality and compliance standards put forward by the Food and Drug Administration (FDA) provide the motivation of the exact and trustworthy analytical methods, such as CE. The market leaders like SCIEX and Agilent Technologies play a crucial role in the design of new CE instruments that have higher sensitivity and throughput in application in the clinical, and industrial markets.

In June 2025, the University of Oklahoma launched its USD 4 million Bioprocessing Core Facility (OU BPCF) to support biomanufacturing education and research. Located in the OKC Innovation District, the facility offers hands-on training with state-of-the-art biomanufacturing equipment, from cell culture to protein purification.

Germany Capillary Electrophoresis Market Trends

Strict regulations of the European Medicines Agency (EMA) support the presence of strong chemical and pharmaceutical industries in Germany that in turn stand out in the market for capillary electrophoresis. The engineering tradition and industrial innovativeness of the country is an added impetus to high performance CE instrumentation. The major actors such as Merck KGaA play a critical role in their integration of CE technologies together with complementary analytical systems to ensure stringent quality assurance.

In January 2024, researchers from Boehringer Ingelheim Pharma, Institute of Pharmaceutical Biotechnology, and Rentschler Biopharma optimized two capillary electrophoresis (CE)-based methods to analyze monoclonal antibodies (mAbs). The study, published in Electrophoresis.

China Capillary Electrophoresis Market Trends

The rapidly growing capillary electrophoresis market in China is anchored by the growing pharmaceutical industry in China and its desire to enhance the healthcare infrastructure. The domestic and foreign players are provided with a good base by the government policies like made in China 2025 and more investments in biotech innovation. Firms such as the Shimadzu Corporation, and local manufacturers are targeting low cost and flexible CE systems that have met the various needs of clinical diagnostics and quality assurance of pharmaceuticals.

In September 2024, Hitachi announced its efforts to leverage its capillary electrophoresis technology to advance cancer diagnosis. The company aims to develop an affordable and efficient genetic testing method that detects multiple genetic mutations in one assay.

Japan Capillary Electrophoresis Market Trends

Japan remains a technological innovator in the market for capillary electrophoresis due to a developed pharmaceutical business and high-quality clinical research centers. The regulatory atmosphere is very strict in the country, requiring the use of high-precision analytical tools, which stimulates the need in innovative CE platforms. The leading companies in the industry like the Hitachi High-Technologies and Tosoh Corporation are instrumental in the development of the CE instrumentation, and they tend to use proprietary technologies to improve their performances and reliability.

For example, Beckman Coulter Life Sciences launched the PA 800 plus next-generation capillary electrophoresis (CE) platform at Pittcon. This automated system provides quantitative analysis of protein purity, charge isoform distribution, and glycan structure. Initially designed for biopharmaceutical analysis, it is now also used in food and beverage quality studies.

End User Feedback and Unmet Needs in the Global Capillary Electrophoresis Market

• End user feedback in the global capillary electrophoresis market highlights both satisfaction and challenges. Users in the pharmaceutical sector value the high-resolution and efficiency of automated systems for protein characterization, noting significant improvements in quality control processes. However, many report difficulties in integrating new systems into existing workflows, as well as a steep learning curve.
• A key unmet need is the lack of customization options, particularly for smaller labs with limited budgets. High costs and limited support for tailored configurations often restrict access to essential technology. Addressing these needs through more affordable, customizable solutions could unlock new market segments, improve customer retention, and drive innovation in the capillary electrophoresis market.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In September 2025, SCIEX, a global leader in life science analytical technologies, introduced native fluorescence detection on the BioPhase 8800 system. This enhancement improves capillary electrophoresis assays like CE-SDS and cIEF by increasing sensitivity and reducing background noise. It offers a faster, more accurate analysis with up to 10x higher sensitivity for protein analysis.
• In March 2025, Thermo Fisher Scientific Inc. launched the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, a new IVDR-compliant capillary electrophoresis system designed for modern clinical labs. This system streamlines genomic testing workflows with enhanced flexibility, user-friendly design, and seamless regulatory compliance for both diagnostic and research applications.
• In September 2024, Hitachi announced its development of a new molecular diagnostic technology aimed at advancing cancer diagnosis. The technology leverages Hitachi's renowned capillary electrophoresis systems to detect a large number of genetic mutations in a single assay.
• In January 2024, Agilent Technologies Inc., a leader in analytical instruments, unveiled the ProteoAnalyzer system. This automated parallel capillary electrophoresis system simplifies protein analysis, enhancing workflows in pharma, biotech, and academia. It offers rapid, high-resolution separation with minimal sample consumption.

Top Strategies Followed by Global Capillary Electrophoresis Market Players

• Existing strongest competitors hold power by heavily investing in the area of research and development (R&D), which allows them to innovate and constantly improve the performance, sensitivity, and versatility of their CE instruments. Development of high-performance products which appeal to the changing needs of industries including pharmaceuticals, biotechnology, and environmental testing is of priority in these companies.
  • Large market leaders in the capillary electrophoresis market are the likes of Beckman Coulter, Horiba Scientific and PerkinElmer who invest in R&D in an effort to enhance the performance, sensitivity, and versatility of their instruments. These firms are suppliers in the high-demand industries such as pharmaceuticals, biotechnology, and environmental testing, and they are constantly inventing with changing industry demands.

• Mid-level companies in the capillary electrophoresis market, use a different strategy in that they aim at providing affordable solutions that balance quality and affordability. The focus of these players is to appeal to price-sensitive clients including academic institutions, small research labs, and mid-sized companies, with reliable instruments of essential features at competitive prices.
  • Middle-range businesses, such as Thermo Fisher scientific and Shimadzu Corporation seek inexpensive solutions without compromising on quality and cost. They work with the price sensitive segments of the market, such as academic institutions, small research labs, as well as mid-sized enterprises, and provide solid instruments with necessary capabilities at a reasonable cost.

• Small competitors in the capillary electrophoresis market cut their niche with either specialized features or novel products that cope with unusual analytical problems. These business organizations are usually pioneers in the use of the latest technologies like microfluidic integration, automation and sophisticated detection techniques to demonstrate the difference and provide customized solutions to specific applications.
  • Microchip Biotechnologies and Tecan Group are small players that focus on innovative products that are distinguished in features. These businesses employ state of the art technologies such as microfluidic integration, automation and sophisticated detection techniques to handle niche applications providing customized solutions to specific analytical needs.

Market Report Scope 

Capillary Electrophoresis Market Dynamics

To learn more about this report, Download Free Sample

Capillary Electrophoresis Market Driver - Rising Prevalence of Infectious Diseases and Chronic Disorders

The growing cases of infectious diseases and chronic conditions across the world are largely driving the demand of high-technological diagnostic methods like the capillary electrophoresis. With the healthcare systems that have to address the multifaceted conditions such as diabetes, cancer, cardiovascular diseases, and multiple infectious pathogenic agents, the necessity of the accurate, quick, and sensitive methods of analysis is acute. Capillary electrophoresis provides a resolution and analysis of biomolecules with high resolution, which makes it an essential instrument in clinical diagnostics, therapeutic monitoring, and biomarker discovery. This is because its capacity to readily identify and measure proteins, nucleic acids and metabolites can be used to enhance better disease diagnosis and therapy.

In September 2025, the World Health Organization (WHO) reported a sharp rise in the global burden of chronic or noncommunicable diseases, which claimed around 43 million lives in 2021 accounting for 75% of non-pandemic-related deaths. The data highlighted cardiovascular diseases, cancers, chronic respiratory conditions, and diabetes as the leading causes, with 80% of premature deaths occurring in low- and middle-income countries. 

Moreover, in October 2024, the World Health Organization (WHO) reported a significant rise in tuberculosis (TB) cases, with approximately 8.2 million new diagnoses in 2023—the highest since WHO began tracking the disease in 1995.

Capillary Electrophoresis Market Opportunity - Integration with Mass Spectrometry and Microfluidic Platforms for Enhanced Capability

The combination of capillary electrophoresis (CE) and modern technology like mass spectrometry (MS) and microfluidic platforms is a considerable expansion potential in the global capillary electrophoresis market. The fusion provides greater analytical functions such as high sensitivity, selectivity, and speed that are essential in the analysis of complex samples in pharmaceuticals, biotechnology and clinical diagnostics. When combined with CE, mass spectrometry allows accurate determination of molecular weight, structural clarification of the analyzed samples, which can provide a more comprehensive understanding of the proteomics and metabolomics process, as well as drug development.

In May 2021, Bio-Techne, a global leader in life sciences tools, and 908 Devices, a pioneer in handheld and desktop mass spectrometry devices, announced a joint collaboration. They are developing an extended workflow solution for protein characterization, combining Bio-Techne's Maurice icIEF separation instrument with 908 Devices' ZipChip device.

Analyst Opinion (Expert Opinion)

• The capillary electrophoresis market is expanding, as new technological innovations, including automation and mass spectrometric analysis, improve the examination of the fields of biopharmaceuticals and diagnostics. This growth is also being fueled by regulatory assistance, but expensive equipment and specialized training are a problem.
• Opportunities include the use of CE in personalized medicine and genomics, where prominent conferences such as Pittcon and Capillary Electrophoresis Workshop are funding new innovations. The market is changing and being influenced by government-supported initiatives and the changing regulations, and CE has become invaluable in the fields of molecular biology and clinical diagnostics.

Market Segmentation

• Product Insights (Revenue, USD Mn, 2020 - 2032)
  • Instruments (automatic systems, semi‑automatic systems)
  • Consumables (capillaries, reagents/buffers, sample vials)
  • Software and Services (analytical software, maintenance and support)
• Mode Insights (Revenue, USD Mn, 2020 - 2032)
  • Capillary Zone Electrophoresis (CZE)
  • Capillary Gel Electrophoresis (CGE)
  • Capillary Electrochromatography (CEC)
  • Capillary Isoelectric Focusing (CIEF)
  • Capillary Isotachophoresis (CITP)
  • Micellar Electrokinetic Capillary Chromatography (MEKC)
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Nucleic Acid Analysis (DNA/RNA sequencing, fragment analysis)
  • Protein/Peptide Analysis (proteomics, post‑translational modifications)
  • Drug Discovery and Development (pharmaceutical QC, impurity profiling)
  • Clinical Diagnostics (disease marker analysis, newborn screening)
  • Others (environmental testing, food and beverage analysis)
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Laboratories (hospital labs, diagnostic centers)
  • Others (contract research organizations)
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Hitachi High‑Tech Corporation
  • Shimadzu Corporation
  • PerkinElmer Inc.
  • Bio‑Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Bio‑Techne Corporation
  • Helena Laboratories Corporation
  • Promega Corporation
  • Takara Bio Inc.
  • Sebia Group
  • 4Basebio PLC

Sources

Primary Research Interviews

• Industry Stakeholders
  • Interviews with instrument manufacturers' senior R&D executives
  • Interviews with consumables suppliers' business development heads
• End Users
  • Interviews with diagnostics lab QC managers using CE systems
  • Interviews with academic research institution separation science leads

Government & International Databases

• European Pharmacopoeia Commission
• U.S. Food & Drug Administration (FDA)
• World Health Organization (WHO)
• National Institutes of Health (NIH)
• Organization for Economic Co-operation and Development (OECD)

Trade Publications

• LCGC International – interview and feature articles on capillary electrophoresis workflows
• Chromatography Today – articles on separation science instrumentation trends
• Bio-Pharm International – features on analytics & biopharma QC instrumentation
• Clinical Lab News – diagnostics lab equipment coverage including CE systems
• Laboratory Equipment – instrumentation launch and adoption summaries
• Analytical Instrument Market News – equipment market commentary & segmentation updates

Academic Journals

• Voeten RLC et al., “Capillary Electrophoresis: Trends and Recent Advances”
• Lu G et al., “Capillary Electrophoresis Separations of Glycans”
• Pont L et al., “A Comprehensive Review on Capillary Electrophoresis–Mass Spectrometry (CE–MS)”
• “Capillary Zone Electrophoresis” entry in ScienceDirect (overview)
• Technical dissertations/theses on CE method development (e.g., Krait, 1983)
• Journal of Pharmaceutical and Biomedical Analysis sections on CE in QC workflows

Reputable Newspapers

• Financial Times – life-sciences equipment investment articles
• The Wall Street Journal – diagnostics instrumentation market news
• The New York Times – healthcare technology/features including lab automation
• The Guardian – science & technology coverage of analytical methods
• Reuters – press coverage of industry contracts/partnerships in analytical instrumentation
• Bloomberg – equipment manufacturers' investment/market shift pieces

Industry Associations

• International Society for Separation Sciences (ISSS)
• Chromatography and Electrophoresis Society (CES)
• European Association for Separation Science (EASS)
• Society for Applied Spectroscopy (SAS) – separation science focus
• American Chemical Society Division of Analytical Chemistry (ACS-DAC)
• Clinical & Laboratory Standards Institute (CLSI) – instrumentation standards

Public Domain Resources

• National library archives of separation science (open theses/dissertations)
• PubMed Central (PMC) full-text articles on CE technology
• Wikipedia entries summarizing CE-MS & electrophoresis
• National government open data portals tracking lab instrumentation imports/exports
• OpenPR press-release aggregators covering instrumentation categories

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years